These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [PRESENT ORIENTATIONS ON THERAPY OF ACUTE ISCHEMIA OF THE LIMBS]. ZANNINI G; JOVINO R; SANTANGELO ML Policlinico Chir; 1964 Oct; 71():249-90. PubMed ID: 14245972 [No Abstract] [Full Text] [Related]
24. THE USE OF UROKINASE IN THE ANTERIOR CHAMBER OF THE EYE. PIERSE D; LEGRICE H J Clin Pathol; 1964 May; 17(3):362. PubMed ID: 14159484 [No Abstract] [Full Text] [Related]
25. The activation of plasminogen by staphylokinase: comparison with streptokinase. DAVIDSON FM Biochem J; 1960 Jul; 76(1):56-61. PubMed ID: 13814337 [No Abstract] [Full Text] [Related]
26. [THERAPY OF THROMBOEMBOLISM AND FIBRINOLYSIS]. SANTOSTORIBIO F Prog Ter Clin; 1963 Oct; 17():9-18. PubMed ID: 14097889 [No Abstract] [Full Text] [Related]
27. [USE OF SOME ENZYMES FOR THERAPEUTIC PURPOSES]. KRUSHKOV I Suvr Med (Sofiia); 1963; 14():46-51. PubMed ID: 14064612 [No Abstract] [Full Text] [Related]
28. AN OBJECTIVE EVALUATION OF THE SPREADING ENZYMES IN THE TREATMENT OF EXPERIMENTALLY PRODUCED LYMPHEDEMA. FELDER ME; BENNETT JE J Trauma; 1965 Jan; 5():43-52. PubMed ID: 14255174 [No Abstract] [Full Text] [Related]
29. The use of the proteolytic enzymes in surgery. MILLER JM Bull Sch Med Univ Md; 1956 Jul; 41(3):75-8. PubMed ID: 13342727 [No Abstract] [Full Text] [Related]
30. Proteolytic activity of guinea pig serum activated by streptokinase-human plasminogen preparations. MEYERS WM; BURDON KL Am J Physiol; 1957 Aug; 190(2):303-9. PubMed ID: 13458461 [No Abstract] [Full Text] [Related]
32. SOME CONSIDERATIONS IN THE SYSTEMIC USE OF FIBRINOLYTIC AGENT. COON WW Mich Med; 1964 Jul; 63():488-90. PubMed ID: 14182774 [No Abstract] [Full Text] [Related]
33. [TRYPSIN-CHYMOTRYPSIN IN THE VASCULAR OCCLUSIVE PROCESSES]. MOSSO HE; PERGOLA F; MARCEILLAC E Prensa Med Argent; 1963 Apr; 50():1081-4. PubMed ID: 14089189 [No Abstract] [Full Text] [Related]
34. RECENT THERAPEUTIC ASPECTS OF THROMBOLYSIS. SCHMUTZLER R Sangre (Barc); 1964; 41():375-6. PubMed ID: 14248821 [No Abstract] [Full Text] [Related]
35. The activation of human plasminogen. II. A kinetic study of activation with trypsin, urokinase, and streptokinase. ALKJAERSIG N; FLETCHER AP; SHERRY S J Biol Chem; 1958 Jul; 233(1):86-90. PubMed ID: 13563446 [No Abstract] [Full Text] [Related]
36. METHOD OF ANTIPLASMIN ASSAY IN HUMAN PLASMA. MAKI M; SAITO H; YONEYA T Tohoku J Exp Med; 1964 Jul; 83():168-78. PubMed ID: 14216987 [No Abstract] [Full Text] [Related]
37. Inhibition of plasmin, trypsin and the streptokinase-activated fibrinolytic system by 6-aminocaproic acid. ABLONDI FB; HAGAN JJ; PHILIPS M; DE RENZO EC Arch Biochem Biophys; 1959 May; 82(1):153-60. PubMed ID: 13650650 [No Abstract] [Full Text] [Related]
38. EFFECT OF GLYCEROL ON THE RESISTANCE OF BLOOD AND PLASMA CLOTS TO THE ACTION OF PROTEOLYTIC ENZYMES. ABEYARATNE MR; PORTER IA; WALDER DN Nature; 1964 Apr; 202():98-9. PubMed ID: 14166737 [No Abstract] [Full Text] [Related]
39. THE INHIBITION OF TRASYLOL OF FIBRINOLYTIC ACTIVITY ASSOCIATED WITH CARDIOVASCULAR OPERATIONS. TICE DA; WORTH MH; CLAUSS RH; REED GH Surg Gynecol Obstet; 1964 Jul; 119():71-4. PubMed ID: 14179354 [No Abstract] [Full Text] [Related]